Vizz is the first and only aceclidine-based eye drop to improve near vision in adults with presbyopia. Vizz contracts the iris sphincter muscle resulting in a pinhole effect, achieving a pupil <2 mm, ...

What is it, and why does it matter? Vizz (aceclidine ophthalmic solution) is a new prescription eye drop approved to treat presbyopia, a common condition that makes it harder to see things up close as ...

The first aceclidine-based eye drop to improve near vision in adults with presbyopia, which affects more than 100 million adults in the US alone, has been approved by the Food and Drug Administration ...

The Food and Drug Administration has approved the first aceclidine-based eye drop designed to improve near vision in adults with presbyopia. This age-related condition affects more than 100 million ...

VIZZ improved near vision in 30 mins with effects lasting up to 10 hours in Phase 3 trials. LENZ may earn over $195 million from licensing deals in Asia and Canada, plus double-digit royalties.

VIZZ is the first and only aceclidine-based eye drop approved to improve near vision in adults with presbyopia, a condition impacting approximately 128 million adults in the United States First once ...

The FDA has approved a first-of-its-kind eye drop that addresses a common vision condition. The once-daily drops will treat an age-related condition that causes blurry near vision. The drops are ...

MR-141 met primary endpoint with ≥3-line near vision gain at 12 hours post-dose on Day 8 vs. placebo (p<0.0001). No serious adverse events; most common side effects were mild, including eye redness ...

TUESDAY, Aug. 5, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved Vizz 1.44 percent (aceclidine ophthalmic solution) for the treatment of presbyopia in adults. Vizz is the ...

Another option for relief is on the way for those who have to bring a restaurant menu close to the face to order or who hold books at arms length to make out text: the Food and Drug Administration ...